-
AI & Machine Learning in Biotechnology1 week agoEli Lilly’s deal man, Allogene’s off-the-shelf CAR-T, and Merck’s Terns buy
On this week’s episode of “The Readout LOUD”: Allison DeAngelis is still away, leaving Elaine Chen and Adam Feuerstein to mind the podcasting store. You’ve been warned....
-
AI & Machine Learning in Biotechnology1 week agoSTAT+: Denali Therapeutics, Corcept Therapeutics win FDA approvals
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The FDA granted accelerated approval...
-
AI & Machine Learning in Biotechnology1 week agoHealth influencers talk social media and mental health
A jury in Los Angeles has found social media giants Google and Meta liable for the mental health struggles of a 20-year-old woman, awarding her $3...
-
AI & Machine Learning in Biotechnology1 week agoSTAT+: A surprise opening for health care reforms
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
-
AI & Machine Learning in Biotechnology1 week agoWhite House misses deadline to nominate new CDC director
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. So you know how Theresa said yesterday that...
-
AI & Machine Learning in Biotechnology1 week agoSTAT+: Data show people racing to chatbots for health advice
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your...
-
AI & Machine Learning in Biotechnology2 weeks ago
Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses
Pulmatrix may have been discarded by Cullgen, but the inhaled therapy biotech’s Nasdaq listing has caught the attention of another company.Read More
